The NADase CD38 may not dictate NAD levels in brain mitochondria of aged mice but regulates hydrogen peroxide generation
- PMID: 37774804
- DOI: 10.1016/j.freeradbiomed.2023.09.035
The NADase CD38 may not dictate NAD levels in brain mitochondria of aged mice but regulates hydrogen peroxide generation
Abstract
Aging is a time-related functional decline that affects many species. One of the hallmarks of aging is mitochondrial dysfunction, which leads to metabolic decline. The NAD decline during aging, in several tissues, correlates with increase in NADase activity of CD38. Knock out or pharmacological inhibition of CD38 activity can rescue mitochondrial function in several tissues, however, the role of CD38 in controlling NAD levels and metabolic function in the aging brain is unknown. In this work, we investigated CD38 NADase activity controlling NAD levels and mitochondrial function in mice brain with aging. We demonstrate that NADase activity of CD38 does not dictate NAD total levels in brain of aging mice and does not control mitochondrial oxygen consumption nor other oxygen parameters markers of mitochondrial dysfunction. However, for the first time we show that CD38 regulates hydrogen peroxide (H2O2) generation, one of the reactive oxygen species (ROS) in aging brain, through regulation of pyruvate dehydrogenase and alfa-ketoglutarate dehydrogenase, as mitochondria H2O2 leakage sites. The effect may be related to mitochondrial calcium handling differences in CD38 absence. Our study highlights a novel role of CD38 in brain energy metabolism and aging.
Keywords: Aging; Brain mitochondrial metabolism; CD38; Calcium uptake; NAD metabolism; Reactive oxygen species.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest None.
Similar articles
-
CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism.Cell Metab. 2016 Jun 14;23(6):1127-1139. doi: 10.1016/j.cmet.2016.05.006. Cell Metab. 2016. PMID: 27304511 Free PMC article.
-
Regulation of intracellular levels of NAD: a novel role for CD38.Biochem Biophys Res Commun. 2006 Jul 14;345(4):1386-92. doi: 10.1016/j.bbrc.2006.05.042. Epub 2006 May 15. Biochem Biophys Res Commun. 2006. PMID: 16730329
-
CD38 inhibitor 78c increases mice lifespan and healthspan in a model of chronological aging.Aging Cell. 2022 Apr;21(4):e13589. doi: 10.1111/acel.13589. Epub 2022 Mar 8. Aging Cell. 2022. PMID: 35263032 Free PMC article.
-
The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging.Trends Pharmacol Sci. 2018 Apr;39(4):424-436. doi: 10.1016/j.tips.2018.02.001. Epub 2018 Feb 23. Trends Pharmacol Sci. 2018. PMID: 29482842 Free PMC article. Review.
-
The CD38 glycohydrolase and the NAD sink: implications for pathological conditions.Am J Physiol Cell Physiol. 2022 Mar 1;322(3):C521-C545. doi: 10.1152/ajpcell.00451.2021. Epub 2022 Feb 9. Am J Physiol Cell Physiol. 2022. PMID: 35138178 Free PMC article. Review.
Cited by
-
Pathobiochemistry of Aging and Neurodegeneration: Deregulation of NAD+ Metabolism in Brain Cells.Biomolecules. 2024 Dec 6;14(12):1556. doi: 10.3390/biom14121556. Biomolecules. 2024. PMID: 39766263 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials